Mucopolysaccharidosis I, II, and VI: brief review and guidelines for treatment
Autor(a) principal: | |
---|---|
Data de Publicação: | 2010 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UFBA |
Texto Completo: | http://repositorio.ufba.br/ri/handle/ri/13505 |
Resumo: | p.589-604 |
id |
UFBA-2_3a34a698bdfce292d2ce1b48e8bdcea9 |
---|---|
oai_identifier_str |
oai:repositorio.ufba.br:ri/13505 |
network_acronym_str |
UFBA-2 |
network_name_str |
Repositório Institucional da UFBA |
repository_id_str |
1932 |
spelling |
Giugliani, RobertoFederhen, AndressaRojas, Maria Verônica MuñozAcosta, Angelina XavierBonfim, CarmenLourenço, Charles MarquesPimentel, HelenaGiugliani, RobertoFederhen, AndressaRojas, Maria Verônica MuñozAcosta, Angelina XavierBonfim, CarmenLourenço, Charles MarquesPimentel, Helena2013-11-01T19:51:31Z2013-11-01T19:51:31Z2010Genetics and Molecular Biologyhttp://repositorio.ufba.br/ri/handle/ri/13505v. 33, n. 4p.589-604Mucopolysaccharidoses (MPS) are rare genetic diseases caused by the deficiency of one of the lysosomal enzymes involved in the glycosaminoglycan (GAG) breakdown pathway. This metabolic block leads to the accumulation of GAG in various organs and tissues of the affected patients, resulting in a multisystemic clinical picture, sometimes including cognitive impairment. Until the beginning of the XXI century, treatment was mainly supportive. Bone marrow transplantation improved the natural course of the disease in some types of MPS, but the morbidity and mortality restricted its use to selected cases. The identification of the genes involved, the new molecular biology tools and the availability of animal models made it possible to develop specific enzyme replacement therapies (ERT) for these diseases. At present, a great number of Brazilian medical centers from all regions of the country have experience with ERT for MPS I, II, and VI, acquired not only through patient treatment but also in clinical trials. Taking the three types of MPS together, over 200 patients have been treated with ERT in our country. This document summarizes the experience of the professionals involved, along with the data available in the international literature, bringing together and harmonizing the information available on the management of these severe and progressive diseases, thus disclosing new prospects for Brazilian patients affected by these conditions.Submitted by Suelen Reis (suziy.ellen@gmail.com) on 2013-07-15T14:24:16Z No. of bitstreams: 1 2010-050.pdf: 140337 bytes, checksum: 8178891b23f375cc4f7fd8a9dca6b4ae (MD5)Approved for entry into archive by Rodrigo Meirelles (rodrigomei@ufba.br) on 2013-11-01T19:51:30Z (GMT) No. of bitstreams: 1 2010-050.pdf: 140337 bytes, checksum: 8178891b23f375cc4f7fd8a9dca6b4ae (MD5)Made available in DSpace on 2013-11-01T19:51:31Z (GMT). No. of bitstreams: 1 2010-050.pdf: 140337 bytes, checksum: 8178891b23f375cc4f7fd8a9dca6b4ae (MD5) Previous issue date: 2010http://dx.doi.org/10.1590/S1415-47572010005000093reponame:Repositório Institucional da UFBAinstname:Universidade Federal da Bahia (UFBA)instacron:UFBAMucopolisaccharidosesHurler syndromeHunter syndromeMaroteaux-Lamy syndromeEnzyme replacement therapyTreatment guidelinesMucopolysaccharidosis I, II, and VI: brief review and guidelines for treatmentGenetics and Molecular Biologyinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleenginfo:eu-repo/semantics/openAccessORIGINAL2010-050.pdf2010-050.pdfapplication/pdf140337https://repositorio.ufba.br/bitstream/ri/13505/1/2010-050.pdf8178891b23f375cc4f7fd8a9dca6b4aeMD51LICENSElicense.txtlicense.txttext/plain1762https://repositorio.ufba.br/bitstream/ri/13505/2/license.txt1b89a9a0548218172d7c829f87a0eab9MD52TEXT2010-050.pdf.txt2010-050.pdf.txtExtracted texttext/plain88711https://repositorio.ufba.br/bitstream/ri/13505/3/2010-050.pdf.txt871da02abb360b44b0993612e641f8deMD53ri/135052022-07-05 14:03:42.603oai:repositorio.ufba.br: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Repositório InstitucionalPUBhttp://192.188.11.11:8080/oai/requestopendoar:19322022-07-05T17:03:42Repositório Institucional da UFBA - Universidade Federal da Bahia (UFBA)false |
dc.title.pt_BR.fl_str_mv |
Mucopolysaccharidosis I, II, and VI: brief review and guidelines for treatment |
dc.title.alternative.pt_BR.fl_str_mv |
Genetics and Molecular Biology |
title |
Mucopolysaccharidosis I, II, and VI: brief review and guidelines for treatment |
spellingShingle |
Mucopolysaccharidosis I, II, and VI: brief review and guidelines for treatment Giugliani, Roberto Mucopolisaccharidoses Hurler syndrome Hunter syndrome Maroteaux-Lamy syndrome Enzyme replacement therapy Treatment guidelines |
title_short |
Mucopolysaccharidosis I, II, and VI: brief review and guidelines for treatment |
title_full |
Mucopolysaccharidosis I, II, and VI: brief review and guidelines for treatment |
title_fullStr |
Mucopolysaccharidosis I, II, and VI: brief review and guidelines for treatment |
title_full_unstemmed |
Mucopolysaccharidosis I, II, and VI: brief review and guidelines for treatment |
title_sort |
Mucopolysaccharidosis I, II, and VI: brief review and guidelines for treatment |
author |
Giugliani, Roberto |
author_facet |
Giugliani, Roberto Federhen, Andressa Rojas, Maria Verônica Muñoz Acosta, Angelina Xavier Bonfim, Carmen Lourenço, Charles Marques Pimentel, Helena |
author_role |
author |
author2 |
Federhen, Andressa Rojas, Maria Verônica Muñoz Acosta, Angelina Xavier Bonfim, Carmen Lourenço, Charles Marques Pimentel, Helena |
author2_role |
author author author author author author |
dc.contributor.author.fl_str_mv |
Giugliani, Roberto Federhen, Andressa Rojas, Maria Verônica Muñoz Acosta, Angelina Xavier Bonfim, Carmen Lourenço, Charles Marques Pimentel, Helena Giugliani, Roberto Federhen, Andressa Rojas, Maria Verônica Muñoz Acosta, Angelina Xavier Bonfim, Carmen Lourenço, Charles Marques Pimentel, Helena |
dc.subject.por.fl_str_mv |
Mucopolisaccharidoses Hurler syndrome Hunter syndrome Maroteaux-Lamy syndrome Enzyme replacement therapy Treatment guidelines |
topic |
Mucopolisaccharidoses Hurler syndrome Hunter syndrome Maroteaux-Lamy syndrome Enzyme replacement therapy Treatment guidelines |
description |
p.589-604 |
publishDate |
2010 |
dc.date.issued.fl_str_mv |
2010 |
dc.date.accessioned.fl_str_mv |
2013-11-01T19:51:31Z |
dc.date.available.fl_str_mv |
2013-11-01T19:51:31Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://repositorio.ufba.br/ri/handle/ri/13505 |
dc.identifier.issn.none.fl_str_mv |
Genetics and Molecular Biology |
dc.identifier.number.pt_BR.fl_str_mv |
v. 33, n. 4 |
identifier_str_mv |
Genetics and Molecular Biology v. 33, n. 4 |
url |
http://repositorio.ufba.br/ri/handle/ri/13505 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.source.pt_BR.fl_str_mv |
http://dx.doi.org/10.1590/S1415-47572010005000093 |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UFBA instname:Universidade Federal da Bahia (UFBA) instacron:UFBA |
instname_str |
Universidade Federal da Bahia (UFBA) |
instacron_str |
UFBA |
institution |
UFBA |
reponame_str |
Repositório Institucional da UFBA |
collection |
Repositório Institucional da UFBA |
bitstream.url.fl_str_mv |
https://repositorio.ufba.br/bitstream/ri/13505/1/2010-050.pdf https://repositorio.ufba.br/bitstream/ri/13505/2/license.txt https://repositorio.ufba.br/bitstream/ri/13505/3/2010-050.pdf.txt |
bitstream.checksum.fl_str_mv |
8178891b23f375cc4f7fd8a9dca6b4ae 1b89a9a0548218172d7c829f87a0eab9 871da02abb360b44b0993612e641f8de |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da UFBA - Universidade Federal da Bahia (UFBA) |
repository.mail.fl_str_mv |
|
_version_ |
1808459451533885440 |